Greg M Allen

6PUBLICATIONS
56CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular, biological, and multi-scale communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 12, 2026
In vivo genome-wide CRISPR screens of human T cells in solid tumours.

|Dec 05, 2024
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.

Nishith R Reddy, Hasna Maachi, Yini Xiao

|Jul 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.

Collin M Blakely, Anatoly Urisman, Matthew A Gubens

|Dec 15, 2022
Synthetic cytokine circuits that drive T cells into immune-excluded tumors.

Greg M Allen, Nicholas W Frankel, Nishith R Reddy

|Sep 29, 2022
Rethinking cancer targeting strategies in the era of smart cell therapeutics.

Greg M Allen, Wendell A Lim

|Nov 27, 2020
Precise T cell recognition programs designed by transcriptionally linking multiple receptors.

Jasper Z Williams, Greg M Allen, Devan Shah

Pageof 1

Frequent Collaborators

4 joint publications

Wendell A Lim

2 joint publications

Kole T Roybal

2 joint publications

Wei Yu

1 joint publications

Jasper Z Williams